"Administration, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The giving of drugs, chemicals, or other substances by mouth.
Descriptor ID |
D000284
|
MeSH Number(s) |
E02.319.267.100
|
Concept/Terms |
Administration, Oral- Administration, Oral
- Drug Administration, Oral
- Oral Drug Administration
- Oral Administration
- Administrations, Oral
- Oral Administrations
- Administration, Oral Drug
- Administrations, Oral Drug
- Drug Administrations, Oral
- Oral Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Oral".
Below are MeSH descriptors whose meaning is more specific than "Administration, Oral".
This graph shows the total number of publications written about "Administration, Oral" by people in this website by year, and whether "Administration, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 12 | 12 |
1995 | 0 | 13 | 13 |
1996 | 0 | 15 | 15 |
1997 | 0 | 15 | 15 |
1998 | 0 | 30 | 30 |
1999 | 0 | 20 | 20 |
2000 | 0 | 19 | 19 |
2001 | 1 | 18 | 19 |
2002 | 0 | 26 | 26 |
2003 | 0 | 36 | 36 |
2004 | 0 | 36 | 36 |
2005 | 0 | 32 | 32 |
2006 | 1 | 40 | 41 |
2007 | 0 | 34 | 34 |
2008 | 0 | 34 | 34 |
2009 | 0 | 34 | 34 |
2010 | 0 | 37 | 37 |
2011 | 0 | 40 | 40 |
2012 | 0 | 32 | 32 |
2013 | 0 | 29 | 29 |
2014 | 1 | 30 | 31 |
2015 | 1 | 48 | 49 |
2016 | 0 | 33 | 33 |
2017 | 0 | 37 | 37 |
2018 | 0 | 50 | 50 |
2019 | 0 | 36 | 36 |
2020 | 0 | 43 | 43 |
2021 | 0 | 42 | 42 |
2022 | 0 | 16 | 16 |
2023 | 0 | 14 | 14 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Oral" by people in Profiles.
-
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis. N Engl J Med. 2024 Feb 29; 390(9):783-794.
-
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis. N Engl J Med. 2024 Feb 29; 390(9):795-805.
-
Safety and Effectiveness of Direct Oral Anticoagulants for the Treatment of Gastrointestinal Cancer-Associated Venous Thromboembolism. Oncologist. 2023 Nov 02; 28(11):e1005-e1016.
-
Worsening Emesis and Oral Intolerance in a Nonverbal 17-year-old Boy. Pediatr Rev. 2023 11 01; 44(11):655-658.
-
Discarded Targeted Oral Anticancer Medication-A Hard Pill to Swallow? JAMA Oncol. 2023 09 01; 9(9):1202-1204.
-
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma. N Engl J Med. 2023 Sep 14; 389(11):1009-1022.
-
Updates in food allergen immunotherapy. Curr Opin Pediatr. 2023 12 01; 35(6):680-685.
-
Food Oral Immunotherapy: A Survey Among US Practicing Allergists Conducted as a AAAAI Leadership Institute Project and Work Group Report. J Allergy Clin Immunol Pract. 2023 08; 11(8):2330-2334.
-
Oral food challenges: Measuring what counts. J Allergy Clin Immunol. 2023 07; 152(1):50-52.
-
Enhancing oral delivery of plant-derived vesicles for colitis. J Control Release. 2023 05; 357:472-483.